Automated cell counters analyze cells in a bodily fluid, most commonly a blood sample. They utilize different techniques like image analysis, fluorometry, impedance, and laser-light scattering to identify white blood cells, red blood cells, and platelets and determine their quantity accurately and quickly. Automated cell counters offer various advantages over manual cell counting methods like enhanced precision, reproducibility, and objectivity of results. The rising prevalence of conditions like cancer, cardiovascular diseases, and infectious diseases has increased the demand for blood analysis and cell counting.

The Global automated cell counters market is estimated to be valued at US$ 3.75 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the automated cell counters are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan. These companies are focusing on new product launches and expanding their offerings to strengthen their market position.

The market provides significant opportunities for players involved in new product development, partnerships with medical device companies and hospitals, and geographical expansion especially in emerging Asian and Latin American countries. Growing prevalence of chronic diseases will drive the need for cell analysis, presenting lucrative business opportunities.

Globally, the automated cell counters market is set to witness high growth owing to increasing healthcare spending, rising awareness, and growing geriatric population in regions like North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Key players are expanding their presence across major countries to capitalize on business opportunities.

Market drivers
- Increasing incidence of infectious, respiratory and cardiovascular diseases worldwide which require routine blood analysis and cell counting
- Technological advancements offering higher accuracy, faster results and automated analysis reducing manual errors
- Growing healthcare expenditure in developing countries improving access to diagnostic technologies

Market restraints
- High initial costs of automated cell counters limiting adoption in low resource settings
- Stringent regulatory approval process for new systems delaying market entry of innovative products
- Lack of skilled professionals in developing regions for operating advanced cell counters

Segment Analysis

The single cell counters sub-segment dominates the automated cell counters market. Single cell counters allow enumerating live and dead cells accurately which is a crucial requirement in various medical applications like cancer research, infectious disease diagnostics. These cell counters provide high throughput analysis of single cells in suspension while maintaining the structural and phenotypic properties of individual cells. This precise count of cells at single cell resolution enables researchers to obtain reproducible and reliable results for cell-based assays.

The multi-mode readers sub-segment is the fastest growing in the automated cell counters market. Multi-mode readers are fully automated benchtop instruments that combine multiple assays like cell counting, viability assessment, population analysis in a single device. These readers find wide usage in stem cell research, immunotherapy development, vaccine manufacturing. They allow analyzing complex cell samples for multiple parameters simultaneously in a high-throughput workflow. This significantly improves experimental throughput and handles sample-to-sample variabilities.

Global Analysis

The North American region dominates the global automated cell counters market. This is attributed to factors like robust healthcare infrastructure, rising pharmaceutical and biotechnology research activities in the region. Presence of leading life sciences companies and academic research institutes driving demand for advanced cell analysis tools. The Asia Pacific region witnesses the fastest growth in the market. This is due to increasing healthcare spending, expanding biosciences industry, growing R&D investments in countries like China and India. China is spearheading the regional market growth on back of flourishing biomanufacturing industry and improving biomedical research scenario in the country. Europe is another major regional market supported by strong academic and industrial research base.

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191